Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1 by Chandele, Anmol et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells
during infection is regulated by the opposing functions of
GABPalpha and Gfi-1
Citation for published version:
Chandele, A, Joshi, NS, Zhu, J, Paul, WE, Leonard, WJ & Kaech, SM 2008, 'Formation of IL-7Ralphahigh
and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and
Gfi-1' Journal of Immunology, vol. 180, no. 8, pp. 5309-19.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of Immunology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Formation of IL-7Rαhi and IL-7Rαlo CD8 T cells during infection is
regulated by the opposing functions of GABPα and Gfi-1
Anmol Chandele1, Nikhil S Joshi1, Jinfang Zhu2, William E. Paul2, Warren J. Leonard3, and
Susan M Kaech1
1Dept of Immunobiology, Yale Medical School, TAC S640, 300 Cedar Street, New Haven, CT 06511.
2Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, MD 20892, USA.
3Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes
of Health, Bethesda, Maryland 20892.
Abstract
IL-7 is essential for survival of naïve and memory T cells, and IL-7 receptor alpha chain (IL-7Rα)
expression is dynamically regulated in activated CD8 T cells during acute viral and bacterial
infections. Most virus-specific CD8 T cells become IL-7Rαlo and are relatively short-lived, but some
escape IL-7Rα repression (referred to as IL-7Rαhi memory precursor effector cells (MPECs)) and
preferentially enter the memory CD8 T cell pool. How anti-viral effector CD8 T cells regulate
IL-7Rα expression in an “on and off” fashion remains to be characterized. During LCMV infection,
we found that opposing actions of the transcription factors GABPα and Gfi-1 control IL-7Rα
expression in effector CD8 T cells. Specifically, GABPα was required for IL-7Rα expression in
MPECs and this correlated with hyperacetylation of the Il7ra promoter. On the other hand, Gfi-1
was required for stable IL-7Rα repression in effector CD8 T cells and acted by antagonizing
GABPα binding and recruiting HDAC1, which deacetylated the Il7ra promoter. Thus, Il7ra promoter
acetylation and activity was dependent on the reciprocal binding of GABPα and Gfi-1, and these
data provide a biochemical mechanism for the generation stable IL-7Rαhi and IL-7Rαlo states in
virus-specific effector CD8 T cells.
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Introduction
Interleukin-7 (IL-7) plays an essential role in lymphocyte development and survival and has
been shown to be a key regulator of memory T cell homeostasis (1,2). IL-7 signals are
transduced through the high-affinity IL-7 receptor alpha chain (IL-7Rα) and the common
cytokine receptor gamma chain (γc; CD132) (1,3). IL-7R signals downstream through at least
two major signal transduction pathways, the JAK/STAT and PI3K/AKT pathways, which
together induce expression of several genes that promote T cell growth and proliferation and
survival (4–7).
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The expression of IL-7Rα is dynamically controlled at many different stages during the life of
T and B cells. For example, in the development of mature naïve B and T cells, IL-7Rα is
expressed by common lymphoid progenitors (CLPs), but then is downregulated during the
transition from pre-B to immature and mature B cells (8). During thymocyte development,
IL-7Rα is expressed by double negative (DN) 1 and 2 cells, then repressed as they progress to
the double positive (DP) stage, and finally, it is re-expressed on single positive (SP) mature T
cells and maintained on naïve CD4 and CD8 T cells in the periphery (9,10). Survival of mature
naïve T cells as they circulate between blood and secondary lymphoid organs requires
IL-7:IL-7Rα signaling (1,2).
When a naïve T cell encounters antigen during infection, and enters a new phase of
differentiation, IL-7Rα is downregulated once again as the activated T cells clonally expand
and differentiate into effector T cells (11–14). Several reports have shown that during acute
infections in mice, such as lymphocytic choriomeningitis virus (LCMV) and Listeria
monocytogenes, the majority of the antigen-specific CD8 T cells express low levels of
IL-7Rα (referred to as IL-7Rαlo) at the peak of expansion (11,12,14,15). However, a small
subset of the effector CD8 T cells express higher amounts of IL-7Rα (referred to as
IL-7Rαhi), and these two subsets have been shown to have different cell fates (12,14). The
IL-7Rαhi effector CD8 T cells have been considered memory precursor effector cells (MPECs)
because they preferentially survive and develop into a stable long-lived memory CD8 T cell
population that can protect against secondary infection and self-renew through homeostatic
turnover (12,16). These MPECs require functional IL-7Rα to become long-lived memory CD8
T cells (2,12,17), and a similar process likely occurs in memory CD4 T cell development
(18,19). In contrast, the IL-7Rαlo CD8 T cell subset is relatively short-lived and only poorly
forms memory T cells (12,16). The majority of the antiviral IL-7Rαlo effector cells do not
appear to convert to an IL-7Rαhi state, indicating stable repression of the IL-7Rα locus is
maintained over time in the absence of antigenic stimulation (20). Although it is likely that the
steady IL-7 deprivation contributes the finite lifespan of IL-7Rαlo cells, recent data over
expressing IL-7Rα on these cells shows that IL-7Rα downregulation is symptomatic of, but
not causal to the bulk effector cell death that occurs after viral clearance (21). These
IL-7Rαlo cells become dependent on IL-15, but this does not sustain them long-term (20).
Considering that fairly stable changes in IL-7Rα expression accompany the decision to become
a memory T cell or not, and that memory T cell longevity is functionally dependent on
IL-7Rα expression, it is important to understand how IL-7Rα expression is regulated in antigen-
specific T cells during immune responses. Currently, most evidence suggests that control of
IL-7Rα expression in T cells is mediated primarily through changes in Il7ra gene transcription
(12,13,22,23), but very few of the mechanistic details of this process are known. Multiple
signals can affect Il7ra transcription in T cells including IL-7 (23), IL-2 (24) and TCR signaling
that repress (13,25), and glucocorticoids (13,26) that induce Il7ra transcription. In addition, a
few transcription factors have been identified that directly bind to and control Il7ra expression.
Two transcription factors (TFs) of the ets family, PU.1 and GA binding protein alpha
(GABPα; also known as (aka) NRF-2 and E4TF1-60), bind to the same site in the Il7ra
promoter and activate its transcription(27–29). GABPαis part of a heterodimeric complex that
includes GABPβ (aka NRF1) that can activate transcription and recruit histone
acetyltransferases (HATs) (30). In B cell progenitors, both GABP and PU.1 drive IL-7Rα
expression (28,31), but in thymocytes and naïve T cells GABP alone performs this function
(29). The reason behind the separation of functions of PU.1 and GABP in the different
lymphocyte lineages is not clear. Moreover, it is not known if GABP functions in memory T
cells or their precursors to maintain IL-7Rα expression. To date, growth factor independence
1 (Gfi-1) is the only known IL-7Rα transcriptional repressor in T cells; it binds to introns 2
and 4 of the Il7ra gene and downregulates expression following IL-7 signaling(23). Gfi-1 has
been shown to recruit G9a histone lysine methylase, ETO proteins and histone deacetylases
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(HDACs), to mediate transcriptional repression of other genes (32). Whether Gfi-1 acts at other
stages of T cell development or following TCR activation to silence the IL-7Rα locus remains
to be determined.
The aims of this study were to determine how Il7ra is transcriptionally regulated in antigen-
specific effector and memory CD8 T cells following LCMV infection in mice. In particular,
we examined if epigenetic modifications of chromatin and the binding of GABPα or Gfi-1
were associated with different transcriptional states of Il7ra in effector and memory CD8 T
cells. Our data suggests that Gfi-1 and GABPα function in a “ying-yang” relationship during
effector CD8 T cell development. Gfi-1 is necessary and sufficient to maintain hypoacetylation
of histones and stable Il7ra repression in late-stage effector CD8 T cells. Conversely,
GABPα helps to maintain histone acetylation and Il7ra transcription in IL-7Rαhi MPECs.
Together, these data provide a mechanistic outline of Il7ra transcriptional regulation as effector
and memory CD8 T cells differentiate during viral infection.
Results
Transcriptional repression of Il7ra in LCMV-specific effector CD8 T cells is associated with
histone deacetylation and HDAC recruitment
To more thoroughly characterize the kinetics and mechanism(s) of Il7ra repression during
effector CD8 T cell differentiation, we first measured IL-7Rα protein and mRNA levels as well
as histone acetylation and HDAC binding to the Il7ra promoter region (from bps −60 thru
−295) (Fig. 1A). Two experimental systems, employing endogenous or P14 TCR transgenic
(tg) LCMV-specific CD8 T cells, were used to measure effector CD8 T cell IL-7Rα expression
as they clonally expand and differentiate in response to LCMV infection. The use of P14 CD8
T cells facilitated earlier detection and isolation of large numbers of the LCMV-specific CD8
T cells; for these experiments, a small number of congenically-marked Thy1.1+ naïve P14
CD8 T cells (<10,000 cells), specific for LCMV epitope DbGP33-41, were adoptively
transferred into C57BL/6 mice (Thy1.2+) that were subsequently infected with LCMV.
The surface expression of IL-7Rα was measured using flow cytometry and the gates for
IL-7Rαhi and IL-7Rαlo T cells were created based on two criteria: (1) the IL-7Rα staining
pattern of total lymphocytes because the two populations of IL-7Rαhi and IL-7Rαlo cells were
clearly identifiable (Fig. 1B, top row, left plot), and (2) the treatment of effector CD8 T cells
with IL-7 because this treatment virtually abolishes detection of IL-7Rα on T cells (23). (Fig.
1B, top row, right plot). Naive CD8 T cells are for the most part uniformly IL-7Rαhi (median
fluorescence intensity (MFI)=50±5), but within ~4 days of infection IL-7Rα levels dropped
considerably on most of the activated CD8 T cells in the spleen (Fig. 1B, bottom row). Both
the frequency and number of IL-7Rαlo cells steadily increased with each passing day of
infection, until day 7–8 post infection (pi) when virus was cleared and effector CD8 T cell
expansion peaked. Although a population of IL-7Rαhi cells was consistently present at each
time point (based on staining after IL-7 treatment), the IL-7Rαhi effector cell population
became more discernable by day 8 pi (Fig. 1B, bottom row). Previous studies have shown that
these IL-7Rαhi effector CD8 T cells present at day 8 pi preferentially develop into long-lived
memory CD8 T cells, and hence, are referred to as memory precursor effector cells (MPECs)
(12,20). Consequently, the majority of memory P14 CD8 T cells found at days 40+ pi were
IL-7Rαhi (12) (Fig 1B, bottom row). Although the proportion of IL-7Rαlo effector CD8 T cells
was larger in the lung and smaller in the iLN relative to the spleen, liver and blood, the overall
kinetics of IL-7Rα repression on effector CD8 T cells occurred similarly in these tissues,
indicating that the formation of IL-7Rαlo CD8 T cells was not compartmentalized to a particular
tissue (data not shown).
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To determine if a decrease in IL-7Rα mRNA mirrored the reduction of surface IL-7Rα
expression, the P14 CD8 T cells were purified at days 5 and 8 pi by FACS and IL-7Rα mRNA
levels were measured using quantitative real-time PCR (qRT-PCR). Compared to naïve CD8
T cells, IL-7Rα mRNA levels dropped ~5–9 fold in the effector CD8 T cells, consistent with
significant transcriptional repression in these cells (Fig.1C). Further comparison of day 8
effector CD8 T cells that were separated based on IL-7Rαhi and IL-7Rαlo expression revealed
that the IL-7Rαhi cells contained ~41 fold more IL-7Rα mRNA than IL-7Rαlo cells (Fig.1C).
Also, the mRNA expression of IL-7Rαhi CD8 T cells was comparable to memory CD8 T cells.
This indicated that IL-7Rα mRNA levels directly correlate with surface protein levels, and that
for the most part, IL-7Rα downregulation during effector cell development is transcriptionally
regulated, as has been previously shown in activated T cells both in vivo and in vitro (12,13).
Next, we determined if the repression of IL-7Rα was associated with chromatin modifications
such as deacetylation of histone amino-terminal tails. Acetylation of histone 3 at lysine residue
9 (H3K9) is one of the most common chromatin modifications associated with active gene
expression, and therefore, this was analyzed by chromatin immunoprecipitation (ChIP) using
antibodies specific for acetylated histone H3K9 in naïve, day 5 and day 8 effector P14 CD8 T
cells. This chromatin immunoprecipitation with primers designed with in the Il7ra promoter
from −294 to −59 bp revealed that the Il7ra promoter (−320 to −41 bp upstream of the
translational start site) was hypoacetylated in day 5 effector cells than in naïve T cells (Fig.
1D). Interestingly, acetylation of the promoter region was regained, and perhaps somewhat
increased, in day 8 effector CD8 T cells. This result was primarily due to the increased
acetylation preferentially found in the IL-7Rαhi effector CD8 T cell subset, which had ~4 fold
greater acetylated H3K9 than did the IL-7Rαlo subset (Fig. 1D). Furthermore, hypoacetylation
of Il7ra promoter correlated with the recruitment of HDAC1 to the promoter, which was
maximal at day 5 pi and remained elevated at day 8 pi, albeit at a level significantly lower than
that observed at day 5 (Fig. 1E). Lastly, to verify whether Il7ra repression could be mediated
through HDAC1 recruitment, via deacetylation of Il7ra locus, naive P14 CD8 T cells were
stimulated with their cognate peptide (GP33–41) in presence or absence of Trichostatin A (TSA),
an HDAC inhibitor (33), and analyzed for surface IL-7Rα expression 24 hrs later. This
experiment showed that TSA inhibited peptide-induced Il7ra repression of activated
(CD69+) CD8 T cells, confirming the involvement of HDACs in Il7ra repression (Fig. 1F). In
summary, these data showed that CD8 T cells repress IL-7Rα as they expand and differentiate
into effector CD8 T cells, and this is associated with recruitment of HDAC1 and histone
deacetylation of the promoter region.
Il7ra downregulation is accompanied with the loss of GABPα binding in vivo
Expression of GABPα is necessary for IL-7Rα expression in thymocytes, but it is unclear if
GABPα regulates IL-7Rα expression in effector and memory CD8 T cells. Therefore, we
examined whether alterations in GABPα binding to the Il7ra promoter were associated with
IL-7Rα mRNA downregulation in the effector CD8 T cells at days 5 and 8 pi. LCMV-specific
P14 CD8 T cells were purified and the amount of GABPα bound to the Il7ra promoter was
measured using ChIP with anti-GABPα antibodies. There was no significant difference in
GABPα binding at day 5 pi as compared to naïve CD8 T cells (Fig. 2A), but surprisingly, the
amount of GABPα bound to the promoter was ~2–3 fold higher in day 8 effector CD8 T cells
compared to naïve or day 5 effector cells. Further analysis showed that it was primarily the
subset of IL-7Rαhi effector CD8 T cells at day 8 pi that contained increased GABPα promoter
binding. Strikingly, even more GABPα was associated with the Il7ra promoter in memory CD8
T cells isolated 40–60 days pi. Together with the data in Figure 1, these results suggest that
the occupancy of GABPα on the Il7ra promoter was important for IL-7Rα expression in
MPECs and correlated with increased histone acetylation (Fig. 1D). Moreover, this analysis
showed that even though naïve and IL-7Rαhi effector and memory CD8 T cells express similar
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amounts of IL-7Rα protein and mRNA, the naïve CD8 T cells achieve IL-7Rα expression with
relatively less histone acetylation and GABPα binding. This may suggest that IL-7Rαhi effector
and memory CD8 T cells require additional post-transcriptional regulatory mechanisms, or
relatively higher levels of histone acetylation and GABP binding in order to achieve similar
IL-7Rα expression as naïve T cells.
GABPα is necessary for increased IL-7Rα expression in MPECs
To directly test the requirement of GABPα for increased IL-7Rα expression in IL-7Rαhi
MPECs, we used shRNAi to knock-down GABPα in LCMV-specific P14 effector CD8 T cells,
similar to that done previously (29). Naïve P14 CD8 T cells were activated and 24hrs later
transduced with either a control retrovirus (RV) or one that express shGapbα. The RV
transduced cells could be identified by GFP expression. First, the efficiency of GABPα knock-
down was verified by sorting on day 8 GFP+ P14 effector CD8 T cells and Western blotting
for GABPα; this showed very efficient knockdown because the GFP+ CD8 T cells expressing
shGabpα contained little to no detectable GABPα protein (Fig. 2B). Next, the RV transduced
P14 CD8 T cells were adoptively transferred into LCMV infected wild type (WT) mice, and
then a week later the donor GFP+ cells were examined for IL-7Rα expression. As expected,
~15–25% of the day 8 GFP+ P14 CD8 T cells transduced with control RV were IL-7Rαhi (Fig.
2C, left plot). In contrast, the frequency of IL-7Rαhi effector cells was substantially reduced
in the GFP+ P14 CD8 T cells transduced with shGABPα RV (Fig 2C, right plot). These results
demonstrated that the increased binding of GABPα to the IL-7Rα promoter in MPECs is
functionally required for their ability to express IL-7Rα.
Gfi-1 regulates formation of IL7Rαlo effector CD8 T cells
Next, we turned our attention to the transcription factor Gfi-1 because it has been shown to
negatively regulate IL-7Rα expression in response to IL-7 signaling (23). However, it is not
known if Gfi-1 functions in effector CD8 T cell differentiation during infection to repress
IL-7Rα. To explore this possibility, we analyzed the expression of Gfi-1 mRNA in naïve and
effector CD8 T cells and found that, as previously reported (34,35), Gfi-1 was not expressed
in naïve CD8 T cells. Early after T cell activation Gfi-1 mRNA was induced and maintained
at relatively high-levels throughout effector cell expansion and memory cell formation.
However, there was no significant difference in Gfi-1 mRNA levels in IL-7Rαhi and
IL-7Rαlo effector CD8 T cells at day 8 pi (data not shown). Thus, Gfi-1 and IL-7Rα expression
do not appear to be inversely correlated as one may have predicted.
To determine if Gfi-1 bound to Il7ra locus during effector CD8 T cell differentiation we
performed ChIP using anti-Gfi-1 antibodies (that do not cross-react with Gfi-1b) and analyzed
binding of Gfi-1 within intron 2 of IL-7Rα as demonstrated previously (23) (see schematic in
Fig. 1A). The level of Gfi-1 binding to Il7ra was nearly below detection in naïve Gfi1+/+ CD8
T cells and Gfi1−/− effector CD8 T cells, confirming both the qRT-PCR data in naïve T cells
and the specificity of the anti-Gfi-1 antibody used in these experiments. But, by day 5 pi the
amount of Gfi-1 bound to Il7ra locus increased considerably (~15 fold increase; Fig. 3A). This
correlated with the greatest repression of Il7ra transcription and HDAC1 recruitment (Fig.1).
Surprisingly, Gfi1 binding to Il7ra was lower in day 8 effector CD8 T cells even though
IL-7Rα expression was significantly repressed in more than 75% of the cells at this time.
However, when day 5 and day 8 IL7Rαhi and IL7Rαlo CD8 T cells were separated and analyzed
directly, Gfi-1 was preferentially bound to the Il7ra gene in the IL-7Rαlo effector cells,
demonstrating a strong correlation between Gfi-1 binding and IL-7Rα repression in virus-
specific effector CD8 T cells (Fig. 3A). These data suggested that Gfi-1 is predominantly
recruited to the Il7ra locus in effector CD8 T cells that will maintain stable repression of
Il7ra and subsequently decline in number following infection.
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To determine if the Gfi-1 binding to IL-7Rα was functionally relevant in effector CD8 T cells,
the Gfi1−/− mice were crossed to the P14 TCR tg strain to obtain Gfi1−/− P14 CD8 T cells, and
then small numbers of Gfi1+/+ or Gfi1−/− P14 CD8 T cells were adoptively transferred into WT
mice that were subsequently infected with LCMV. The levels of IL-7Rα protein and mRNA
were examined on the donor cells at various times pi (Fig. 3B). Both naïve Gfi1−/− and
Gfi1+/+ P14 CD8 T cells expressed similar amounts of IL-7Rα at the protein and mRNA (Fig.
3B, left plots). At day 5 pi, IL-7Rα expression was reduced in LCMV-specific Gfi1−/− cells
compared to naïve T cells, but not as profound as the reduction seen in Gfi1+/+ CD8 T cells
(Fig. 3B, middle plots). By day 8 pi, a small subset (~15–25%) of IL-7Rαhi effector CD8 T
cells formed in the Gfi1+/+ population as expected. In contrast, a substantially larger percentage
(~70–80%) of IL-7Rαhi effector CD8 T cells formed in Gfi1−/− effector CD8 T cells (Fig. 3B,
right plots). The mean fluorescence intensity of IL-7Rα in the effector CD8 T cells is shown
(Fig. 3C, upper line graph). Accordingly, the expression of IL-7Rα mRNA followed a similar
trend and was slightly elevated in day 5 Gfi1−/− effector CD8 T cells compared to Gfi1+/+ cells,
but the day 8 Gfi1−/− effector CD8 T cells contained significantly more IL-7Rα mRNA (Fig.
3C, lower graph).
To determine if the increased IL-7Rα expression in day 8 Gfi1−/− effector CD8 T cells
correlated with decreased HDAC1 binding and/or increased histone acetylation, we performed
ChIP assays in Gfi1+/+ and Gfi1−/− P14 CD8 T cells. This analysis showed that significantly
less (~7 fold) HDAC1 was bound to Il7ra in Gfi1−/− vs. Gfi1+/+ day 8 LCMV-specific CD8 T
cells (Fig. 3D), correlating with the increased IL-7Rα expression in day 8 Gfi-1−/− CD8 T cells.
Moreover, the abundance of acetylated H3K9 on the IL-7Rα promoter in Gfi1−/− P14 effector
CD8 T cells was nearly twice that of the Gfi1+/+ cells (Fig. 3E). Together, these observations
suggested that Gfi-1 was not absolutely required for the early IL-7Rα repression that occurs
when viral infection was present (~day 5 pi), but may be needed subsequently to maintain
stable IL-7Rα repression as antigenic stimulation declines by preserving HDAC1 recruitment
and hypoacetylation of the promoter in the majority of terminally-differentiated effector cells.
Gfi-1 is required for stable repression of Il7ra in late effector CD8 T cells
The analysis above suggested that Gfi-1 was not sufficient for TCR driven repression of
IL-7Rα (day 5 pi), but was needed for stable silencing of the locus in the absence of antigenic
signaling (day 8 pi and later). To examine this point more closely, naïve Gfi1+/+ or Gfi1−/− P14
CD8 T cells were stimulated with peptide in vitro for 12–24 hrs. As previously shown (13,
25), IL-7Rα was rapidly downregulated in Gfi1+/+ CD8 T cells and Gfi-1 was recruited to the
Il7ra locus in these early activated CD8 T cells (Fig. 4A and data not shown). Interestingly,
the Gfi1−/− CD8 T cells exhibited a similar loss of IL-7Rα in response to TCR activation (Fig.
4A). Together, these findings suggested that even though Gfi-1 was recruited to Il7ra in
activated T cells, a Gfi-1-independent mechanism largely operates downstream of TCR
signaling early on to repress Il7r. This helps to explain the nearly normal decrease in IL-7Rα
observed in Gfi1−/− LCMV-specific effector CD8 T cells at day 5 pi when virus was still
prevalent (Fig. 3B, C).
Next, we tested if the abnormally swift transition from IL-7Rαlo to IL-7Rαhi found in
Gfi1−/− effector CD8 T cells between days 5–8 pi was due to direct conversion (i.e., the inability
to sustain Il7ra silencing in late effector Gfi1−/− CD8 T cells) or to the preferential death of
IL-7Rαlo Gfi1−/− cells. At day 5 pi, Gfi1+/+ and Gfi1−/− P14 CD8 T cells (which were
congenically marked Thy1.1+) were sorted by FACS based on IL-7Rαlo expression and then
equal numbers were adoptively transferred separately into congenic (Thy1.2) recipients that
were infected 5 days previously (Fig. 4B). At day 8 pi (3 days later), the IL-7Rαlo donor cells
were examined for IL-7Rα expression. As expected, the majority of the Gfi1+/+ effector CD8
T cells maintained repression of IL-7Rα over this time. In contrast, most of the donor
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Gfi1−/− effector CD8 T cells could not sustain IL-7Rα transcriptional repression and ~60% of
the cells converted to an IL-7Rαhi state within three days (Fig. 4B). These data indicated that
at least two mechanisms of IL-7Rα repression exist in effector CD8 T cells: one form being
driven by TCR signaling that does not require Gfi-1, and another that stably maintains Il7ra
repression in the absence of antigenic signals and requires Gfi-1.
Gfi-1 over expression represses Il7ra by reducing GABPα binding to Il7ra
To further investigate the role of Gfi-1 in IL-7Rα expression in effector CD8 T cells, Gfi-1
was over expressed in LCMV-specific CD8 T cells using RV transduction. P14 CD8 T cells
were activated and transduced with control or Gfi-1 RV and either transferred into LCMV
infected or naïve recipients; the RV transduced cells were marked by GFP expression. This
experiment revealed that over expression of Gfi-1 inhibited the development of a subset of
IL-7Rαhi effector cells during infection (Fig. 5A, right plot). Moreover, when P14 CD8 T cells
were briefly stimulated with peptide for 24hrs in vitro (under low inflammatory conditions)
IL-7Rα repression was transient for the first 24–36 hrs and was then regained as the activated
CD8 T cells continued to clonally expand (Fig. 4A and data not shown). Using this system,
Gfi-1 RV over expression was sufficient to repress IL-7Rα in nearly all of the briefly stimulated
and expanded CD8 T cells (Fig. 5B, right plot).
To assess the effects of Gfi-1 over expression on histone acetylation of the Il7ra promoter,
GFP+ (Gfi-1 RV) and GFP- (no RV) P14 CD8 T cells were sorted and the amount of acetylated
H3K9 was measured using ChIP assays. This analysis showed that Gfi-1 over expression
resulted in profound hypoacetylation of the Il7ra promoter (Fig. 5C). These data in combination
with those shown in Fig. 3 demonstrate that Gfi-1 is necessary and sufficient (when over
expressed) to maintain repression of Il7rα, perhaps via histone H3 deacetylation, during
effector CD8 T cell differentiation.
The above data suggested that GABPα and Gfi-1 have opposing effects on Il7rα transcription;
GABPα binding enhances promoter acetylation and transcription whereas Gfi-1 promotes
HDAC binding, promoter deacetylation and transcriptional silencing. A possibility could be
that over expression of Gfi-1 inhibits binding of the transcriptional activator GABPα to the
Il7ra promoter. To examine this question, we measured the amounts of GABPα bound to
Il7ra promoter using ChIP when Gfi-1 was absent (i.e., Gfi1−/− effector CD8 T cells) or over
expressed by RV transduction. This showed that the amount of GABPα bound to the Il7ra
promoter in day 8 Gfi1−/− effector CD8 T cells was ~1.5–2 fold greater than in Gfi1+/+ cells
(Fig. 5D). This result suggested that GABPα function is important for the increased IL-7Rα
expression in Gfi1−/− effector CD8 T cells. Next, the day 8 effector P14 CD8 T cells over
expressing Gfi-1 were sorted and GFP+ (Gfi-1 RV) and GFP- (no RV) were compared for
GABPα expression and binding. qRT-PCR confirmed that there was no difference in
GABPα mRNA levels (data not shown) in GFP+ and GFP- P14 CD8 T cells, showing that
Gfi-1 over expression did not affect GABPα expression (data not shown). However, ChIP
analysis of GABPα revealed that GFP+ P14 CD8 T cells had ~20.5 fold less GABPα bound
to their Il7ra locus compared to GFP- P14 CD8 T cells (Fig. 5E), indicating that over expression
of Gfi-1 reduces GABPα binding to Il7ra promoter.
Discussion
This study was designed to understand the molecular mechanism(s) that control IL-7Rα
expression in CD8 T cell with expansion and differentiation of IL-7Rαhi MPECs and
IL-7Rαlo SLECs in response to an acute viral infection. We found that IL-7Rα expression is
regulated in these two effector cell populations by a balance between the transcriptional
repressor Gfi-1 and the transcriptional activator GABPα. Here, our results suggest that the
Il7ra locus exists in multiple states as naïve CD8 T cells differentiate into MPECs and SLECs.
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In the first state, in resting naïve CD8 T cells, Gfi-1 is not expressed, Il7ra is transcriptionally
active and the promoter is acetylated with moderate levels GABPα binding. Upon activation,
TCR signaling causes rapid downregulation of IL-7Rα expression and this is correlated with
hypoacetylation of the promoter region and recruitment of HDAC1. Gfi-1 is induced early in
activated T cells and recruited to the Il7ra locus (data not shown), but does not appear essential
for early TCR-dependent Il7ra repression at this stage. As the viral infection is resolved and
effector CD8 T cell expansion peaks around ~ day 8 post infection, the MPECs and SLECs
became easier to discern based on high and low levels of IL-7Rα expression respectively. The
majority of the effector CD8 T cells express little to no IL-7Rα and are considered terminally
differentiated because they have lost the ability to become long-lived memory CD8 T cells.
The reduced IL-7Rα expression in this subset was associated with increased HDAC1
recruitment and decreased GABPα binding and histone acetylation of the promoter. Gfi-1
preferentially bound to the Il7ra locus and was required for stable Il7ra repression in these
cells. When Gfi-1 was over expressed the occupancy of GABPα and promoter acetylation was
reduced even further, suggesting that in addition to recruiting HDACs, Gfi-1 also functions to
repress Il7ra by inhibiting recruitment of a requisite transcriptional activator GABPα.
The Il7ra locus existed in the opposite state in the smaller population of IL-7Rαhi MPECs
where GABPα binding to and histone acetylation of the promoter was abundant, and Gfi-1
binding to intron 2 was significantly decreased. Furthermore, GABPα was functionally
required to sustain IL-7Rα expression in these IL-7Rαhi MPECs. Therefore, since IL-7Rα
expression is functionally required for generation of a pool of memory CD8 T cells, GABPα
is likely required for memory CD8 T cell development and maintenance.
These data offer a model for how the “on” or “off” state of Il7ra is mediated by the binding of
opposing transcriptional activators and repressors and concurrent epigenetic remodeling of the
Il7ra promoter. Interestingly, the primary determinant of Il7ra transcriptional regulation was
not necessarily the differential expression of GABPα or Gfi-1 in IL-7Rαhi or IL-7Rαlo effector
CD8 T cells, but rather it was the preferential recruitment of GABPα or Gfi-1 to the Il7ra locus
in these respective T cell subsets. How is this reciprocal binding pattern of Gfi-1 and
GABPα set-up and maintained in the effector CD8 T cells? GABPα is a target of
phosphorylation by certain kinases such as ERK and JNK (36) (37), and perhaps, differential
activity of these kinases in IL-7Rαhi and IL-7Rαlo effector CD8 T cells contributes to Il7ra
gene regulation. Another possibility is that other signals (aside from TCR activation) stabilize
Gfi-1 binding in the majority of effector CD8 T cells and this directly impairs GABPα docking
to the promoter. Evidence for this idea is provided by prior work that showed that Gfi-1 can
antagonize the transcriptional activation of ets-family members, ETS-1 and PU.1, by direct
binding (38,39). Another possibility is that the transcription factor T-bet (Tbx21) cooperates
with Gfi-1 to antagonize GABPα activity in effector CD8 T cells. Our recent work has shown
that certain inflammatory signals during infection, such as IL-12, directly increase T-bet
expression in effector CD8 T cells and this induces development of IL-7Rαlo SLECs (20). Like
Gfi-1 RV over expression, T-bet RV over expression represses IL-7Rα expression in effector
CD8 T cells (20,40). Therefore, it is possible that increased T-bet stabilizes Gfi-1 recruitment
to the Il7ra locus in effector CD8 T cells that were exposed to high levels of IL-12, but this
question remains to be tested.
As might be expected for a protein whose expression is critical to naïve and memory T cell
generation and maintenance, IL-7Rα expression appears to be tightly regulated by multiple
signals and mechanisms. TCR activation leads to rapid IL-7Rα downregulation, but this TCR-
directed repression is transient and the mechanism by which this occurs is not known. We show
here that TCR-dependent inhibition of IL-7Rα expression is largely independent of Gfi-1 both
in vitro and in vivo (when viral antigens are present). Moreover, this process is also T-bet
independent (data not shown). However, we found that Gfi-1 was necessary to sustain a stable
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repressed state in late effector CD8 T cells (~day 7 onwards) when viral infection and antigenic
stimulation was ceasing. Thus, at least two mechanisms exist, which occur over two phases
during infection, that inhibit IL-7Rα expression in activated CD8 T cells during viral infection.
One is transient repression mediated by TCR signaling, and the other is stable repression that
occurs primarily in terminally differentiated effector CD8 T cells and requires Gfi-1.
Our analysis showed that Il7ra repression in activated CD8 T cells was also associated with
characteristic epigenetic chromatin modifications, namely histone (H3K9) deacetylation via
HDAC1. A previous report showed that increased CpG DNA methylation in the promoter of
IL-7Rαlo CD8 T cells was likely important for maintenance of IL-7Rαlo state in resting effector
memory T cells (TEM) (41). However, DNA methylation did not seem to be involved in the
rapid TCR- or IL-7-directed repression of Il7rα (41). Thus, the epigenetic control of Il7ra
expression appears to involve multiple layers to ensure tight, yet long term, regulation of either
high and low IL-7Rα expression levels in T cells.
Some γc chain cytokines and steroids have also been found to regulate IL-7Rα expression
(13,23,24,26). IL-7 and several other γc chain cytokines induce rapid IL-7Rα downregulation
that is transient in nature because the T cells quickly regain IL-7Rα expression following
removal from high dose cytokine exposure (23,24). It was hypothesized that this temporary
form of IL-7Rα down regulation was an altruistic way by which T cells could decrease
competition for the limiting amounts of IL-7 in the periphery (23). This mode of repression
contrasts to the more “permanent” form of IL-7Rα repression found during effector CD8 T
cell development (12,20). However, in CD8 T cells, but not CD4 T cells, this cytokine-
dependent silencing is Gfi-1 dependent (23). Glucocorticoids provide another signal that
upregulate IL-7Rα expression via binding of the glucocorticoid receptor (GR) to a GR binding
site in a small evolutionary conserved region (ECR) ~3.6kb upstream of the Il7ra promoter
(13,26). Using rVista 2.0 analysis (42), multiple other TF binding sites (such as Foxo1/3/4,
NFκβ, Gata6, Pax3 and Stat1/4) are predicted in this region and serve as additional candidates
to regulate IL-7Rα expression. In addition to this ECR, at least two others can be found using
this analysis in the 6 kb upstream of the Il7ra promoter, but the relevance of these ECRs and
the potential TFs that bind to these regions remains to be determined.
Our data shed light on the biochemical processes by which effector CD8 T cells gain or lose
memory CD8 T cell potential. Currently, very low amounts of surface IL-7Rα is one of the
best markers for effector or memory CD8 T cells that are terminally-differentiated and short-
lived during infections (12,14,16). Therefore, understanding how the repression of IL-7Rα is
initiated and sustained in anti-viral CD8 T cells is key to understanding how this differentiated
state is acquired. In addition to serving as a marker, IL-7Rα downregulation was initially
predicted to be the underlying cause of death of the majority of the effector CD8 T cells after
infection since IL-7 deprivation causes T cell apoptosis (1,7). However, our recent data and
that of others have shown that the bulk of effector T cell contraction that occurs following
infection is IL-7 independent. (21,43,44). When IL-7Rα expression was enforced on all virus-
specific effector CD8 T cells using an Il7ra transgene, this did not rescue the preferential death
of the naturally arising IL-7Rαlo effector CD8 T cell subset (21). Other work showed that this
IL-7Rαlo subset is mainly dependent on IL-15 for survival, however, IL-15 does not suffice to
maintain the IL-7Rαlo CD8 T cells long-term (20). In contrast, the IL-7Rαhi MPECs
functionally require IL-7Rα to persist and develop into long-lived memory CD8 T cells (12,
17,45). Therefore, elucidating that GABPα is required for expression of IL-7Rα in these cells
is an important finding for memory CD8 T cell development.
Numerous target genes have been identified for both GABPα and Gfi-1 (30,46–48), and
therefore, it is important to consider the additional effects, aside from abnormal IL-7Rα
expression, that result in GABPα and Gfi-1-deficient effector CD8 T cells. Interestingly, in
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addition to IL-7Rα, a few other genes such as IL-2, TNFα, and ELA2 are predicted to contain
binding sites for both Gfi-1 and GABPα, and it is possible that these two factors play opposing
roles on their gene expression (47,49–51). It is noteworthy that GABPα also controls the
expression of several genes involved in mitochondrial function, cellular energy metabolism
and cell cycle progression (30,52). It is possible that the coregulated expression of these genes
with Il7ra (via GABPα)in MPECs is vital to their cellular fitness and ability to become long-
lived memory CD8 T cells with a high proliferative potential.
A long-term goal is to elucidate the transcriptional network that controls effector and memory
CD8 T cell differentiation and to identify key transcriptional regulators. Beginning with a gene
vital to memory CD8 T cell development and survival, IL-7Rα, this work provides inroads into
this extremely complex problem. In the future it will be of value to find other genes that are
co-regulated with IL-7Rα, to identify their transcriptional regulators, and to identify if these
represent a cassette of genes critical to memory CD8 T cell formation.
Materials and Methods
Mice and infections
C57BL/6 (B6) mice were purchased from National Cancer Institute (Fredrick, MD) and
Jackson Laboratories (Bar Harbor, ME). Thy1.1+ P14 TCR tg mice have been described
previously (53). Gfi1−/− mice were generously provided by Dr. Stuart Orkin (Children’s
hospital, Boston, MA) (54). For experiments involving P14 tg CD8 T cells, ~1×104 Gfi1+/+ or
Gfi1−/− P14+ CD8 T cells were transferred to make “P14 chimeric mice”. Mice were infected
i.p. with 2×105 PFU of LCMV-Armstrong strain (53).
Cell isolations and separations
Populations of Thy1.1+ CD8 P14 T cells were purified by magnetically depleting non-CD8 T
cells using antibodies to CD4 (GK1.5), B220 (TIB164 and H-2b (TIB120) obtained from K.
Bottomly (Yale University, New Haven, CT), followed by anti-rat IgG and mouse-IgM
magnetic beads (Polysciences Inc, Warrington, PA) and sorted using FACSAria (BD) or MoFlo
(DakoCytomation) cell sorters. Equal numbers of sorted cells were transferred i.v. into B6
recipient mice.
Retroviral (RV) constructs and transduction
P14 Tg mice were directly infected with 2×106 pfu LCMV-Armstrong i.v. and 1 day later, P14
Tg splenocytes were spin transduced for 90 min at 37°C with fresh viral supernatants from
293T cells (transfected 48 hours prior with Eco helper and either MigR1 GFP control, MigR1-
Gfi-1-GFP (55), MSCV-Mir-GFP (MicroRNA cassette containing Xho1 and EcoR1 sites from
the LMP vector (Open Biosystems, Huntsville, AL) was cloned into the MigR1 GFP vector)
or MSCV-Mir-shGabpα–GFP in the presence of 8ug/ml of polybrene and 10ug/ml of IL-2 and
then immediately transferred i.v. to C57BL/6 mice that were subsequently infected with
2×105 PFU LCMV. For experiments involving transfer into naïve mice, ~10×106 P14 CD8 T
cells were cultured for 24 hours with 100ng/ml GP33–41 peptide and spin transduced as
described above to avoid transfer of LCMV into naïve mice. Mice containing RV-transduced
P14 CD8 T cells were sacrificed at day 5 or 8 post transduction and GFP+ P14 CD8 T cells
were analyzed by flow cytometry or sorted using FACSAria (BD) or MoFlo (DakoCytomation)
cell sorters.
Real-time PCR analyses
For real time analysis ~2×105 naïve P14 CD8 T cells, day 5–8 P14 effector CD8 T cells, day
8 IL-7Rαhi and IL-7Rαlo cells, were sorted by FACS. Total RNA was extracted by Trizol
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method using the manufacturers instructions and cDNA was synthesized using SSRTII
(Invitrogen). Real-time PCR analysis was performed as previously described (56). Primers for
IL-7Rα: 5’-GCAGACGCGGACCATCACTC-3’ and 5’- ATTTTTGCAAGTTAAATTCT-3’;
Gfi-1 5’ CTCATTCCTGGTCAAGAGC-3’ and 5’-CATGCATAGGGCTTGAAA-3’ Due to
the extensive homology between Gfi1 and its homologue Gfi1b, real time PCR primers were
chosen in the non homologous regions of the Gfi1 cds: L9: 5’-
TGAAGAAATCTGTGGGTCG-3’ and 5 ’ - GCACTACGGACATAGGAACTC-3’. L9 is a
ribosomal protein gene that is expressed at a relatively constant level in naïve, effector, and
memory CD8 T cells and served as an internal reference. All PCRs used an annealing temp
55°C. Relative fold differences were calculated as described (57).
Western blotting
Protein lysates from 1 × 106 sorted naïve cells (CD8+ CD44lo) or day 5 and day 8 sorted total
effector CD8 T cells were and resolved by SDS-PAGE. Antibodies to GABPα (29), was used
for Western blotting at 1:1000 dilution. The blots were stripped and reprobed with Grp94 (Cell
Signal, Danvers, MA) at a dilution of 1:5000 as normalization control.
Chromatin Immunoprecipitation
ChIP assays were performed with standard procedures (Upstate Biotech, Temecular, VA,
USA). Briefly, DNA was crosslinked with formaldehyde (1% final concentration) and
chromatin was sheared by sonication until an average length of DNA ladder of 500 bp
increments was obtained. Salmon sperm DNA/protein agarose (Upstate Biotech, Temecula,
VA, USA) was used for preclearing and immunoprecipitation. Antibodies against acetyl H3K9
and HDAC1 (Upstate Biotech, Temecula, VA), GABPα (29), and Gfi-1 (gift from Dr. H Bellen,
raised against the SNAG domain that is non-homologous regions between Gfi-1 and Gfi-1B
and is not reactive in Gfi1−/− mice) (58) were used for precipitating the protein-DNA
concentration. Precipitated protein–DNA complexes were washed in low-salt buffer (20 mM
Tris-HCl pH 8.1, 2 mM EDTA, 150 mM NaCl, 0.1% sodium dodecyl sulfate and 1% Triton
X-100), and with TE (10 mM Tris-HCl pH8.1, 1 mM EDTA) buffer twice. The precipitated
protein–DNA complexes were eluted and crosslinks were reversed with NaCl (200mM final
concentration) incubated at 65°C overnight. After treatment with RNase A and proteinase K,
DNA was extracted with phenol/chloroform and precipitated with ethanol. Purified DNA was
then subjected to 40 cycles of PCR amplification. Primers spanned −294 to −59 region within
the Il7ra promoter and the reported binding site for Gfi-1 in intron 2. The primer sequences
for Il7ra promoter forward 5’ GCAGTTAAGTTCAGGAGCTTCAGG 3’ and reverse 5’
GAAGCACGGTTGTATGTGCAAGTG 3’; Il7ra Intron 2 forward
5’CCAGACTATCTAGTCAATGG 3’ and reverse 5’ TTCAAGTCACCAGAGATAAT 3’.
DNA concentration was calculated from a genomic DNA standard 8-fold dilution series and
in most cases fold differences between samples were calculated by normalizing to naive CD8
T cells set at one or calculated as relative DNA concentration with respect to genomic DNA
curve and the initial input DNA.
Statistical Analyses
Where indicated, p-values were determined using a two-tailed unpaired student’s t-test. p-
values <0.05 were considered significant. All graphs show averages of the mean ± s.e.m.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
CLP Common lymphoid progenitor
Pi3K Phosphoinositide – 3 - kinase
AKT Serine threonine protein kinase B (AKT mouse thymoma)
ERK extracellular signal-regulated kinase
JNK c-Jun N-terminal Kinase
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Figure 1. Transcriptional repression of il7rα in LCMV specific effector CD8 T cells is associated
with histone deacetylation and HDAC1 recruitment
A. Map of Il7rα.Il7ra has eight exons shown as numbered rectangles. The transcriptional start
site is +1, and GABPα binds at –185 bp and Gfi-1 binds at +5484 bp. The region of DNA
analyzed for GABPα binding, promoter acetylation, HDAC1 recruitment and Gfi-1 binding
by ChIP are denoted.
B–C. IL-7Rα is down regulated in CD8 T cells after LCMV infection. Naïve P14 CD8 T
cells (Thy1.1+) were adoptively transferred into wild type recipients (Thy1.2+) to make “P14
chimeric mice” that were subsequently infected with LCMV. The amount of IL-7Rα protein
and mRNA was measured in P14 CD8 T cells from naïve P14 mice or P14 chimeric mice
infected 4–8 days previously using flow cytometry (B) and qRT-PCR (C). In (B), top row plots
show gating criteria for IL-7Rαhi and IL-7Rαlo CD8 T cells, which were based on IL-7Rα
expression of total lymphocytes because IL-7Rαhi and IL-7Rαlo cells are clearly visible (top
row, left plot) and CD8 T cells treated with IL-7 because this leads to rapid IL-7Rα
downregulation (top row, right plot). Bottom row plots show expression of IL-7Rα on
Thy1.1+ P14 CD8 T cells from naïve or infected animals. The percentage of IL-7Rαhi cells
and the average mean fluorescent intensity (MFI) of the total population is indicated in each
plot. (C) Thy1.1+ P14 CD8 T cells were FACS sorted from naïve, infected (days 5 and 8 pi)
or immune (day 50+ pi) mice. P14 CD8 T cells from day 8 p.i. were also divided into
IL-7Rαhi and IL-7Rαlo subsets. IL-7Rα mRNA levels were measured from these cell
populations using qRT-PCR. Bar graph shows IL-7Rα mRNA levels relative to L9 ribosomal
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protein gene (a gene whose expression does not vary much with CD8 T cell activation). Data
are mean ± SEM (n=3–6); *=p<0.05.
D–E. IL-7Rα repression after LCMV infection coincides with decreased acetylation and
HDAC1 recruitment. Naïve, day 5, day 8 or IL-7Rαhi and IL-7Rαlo day 8 P14 effector CD8
T cells were purified using FACS and analyzed for acetylated H3K9 histones (D) or HDAC1
binding (E) on the Il7ra promoter using chromatin immunoprecipitation followed by qRT-
PCR. The data in bar graphs were plotted as fold changes in acetylation or HDAC1 recruitment
with respect to naïve T cells set at 1 fold. The graph shows mean ± SEM (n=3); *=p<0.05 and
**=p<0.01.
F. IL-7Rα repression is TSA sensitive. CD8 T cells were stimulated over night with LCMV
peptide GP33–41 with (dashed line) or without (thick line) a non-specific HDAC inhibitor,
trichostatin A. Histogram shows the expression of IL-7Rα in CD69+ activated CD8 T cells
relative to unstimulated, naïve CD8 T cells (filled histogram).
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Figure 2. GABPα is necessary for IL-7Rα expression in LCMV-specific effector CD8 T cells
A. Binding of GABPα to Il7ra promoter correlates with IL-7Rα expression. Naïve, day 5,
day 8 or IL-7Rαhi and IL-7Rαlo day 8 P14 effector CD8 T cells were purified using FACS and
analyzed for GABPα binding on the Il7ra promoter using chromatin immunoprecipitation
followed by qRT-PCR. Bar graph represents fold differences in GABPα pull down with naive
CD8 T cells set at 1 fold. The data are mean ± SEM (n=6); **=p<0.01.
B–C. GABPα is necessary for the formation of IL-7Rαhi effector CD8 T cells. Activated
P14 CD8 T cells were transduced with RVs (marked by GFP+ expression) expressing
shGabpα RNAi or empty control vector and subsequently transferred into LCMV infected
recipients. Seven days pi GFP+ P14 CD8 T cells were analyzed for expression of GABPα
(B) and IL-7Rα (C). In (B), the GFP+ P14 CD8 T cells were purified by FACS and protein
lysates were analyzed for expression of GABPα and Grp-94 (protein loading control) by
Western blotting. In (C), the GFP+ and GFP- P14 CD8 T cells were analyzed for surface
IL-7Rα expression using flow cytometry. Note, specific reduction in the frequency of
IL-7Rαhi effector CD8 T cells in GFP+ P14 CD8 T cells transduced with shGabpα RNAi RV.
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Figure 3. Gfi-1-mediated IL-7Rα repression in ‘late’ effector CD8 T cells is associated with
decreased HDAC1 binding and increased promoter acetylation
A. Gfi-1 preferentially binds to IL-7Rα in IL-7Rαlo effector CD8 T cells. Naïve, day 5, day
8 or IL-7Rαhi and IL-7Rαlo day 5 or day 8 P14 effector CD8 T cells were purified using FACS
and analyzed for Gfi-1 binding on intron 2 using chromatin immunoprecipitation followed by
qRT-PCR. Gfi1−/− CD8 T cells were used to correct against background signal. Bar graph
shows the amount of DNA immunoprecipitated from each sample in ng/ml, based on a genomic
standard. The graph in data are mean ± SEM (n=4); *=p<0.05.
B–C. Gfi-1 is required for IL-7Rα repression in ‘late’ effector CD8 T cells. P14 chimeric
mice containing LCMV-specific Gfi1+/+ and Gfi1−/− P14 CD8 T cells were infected with
LCMV and analyzed for IL-7Rα expression by flow cytometry (B and C, upper graph) and
qRT-PCR (C, lower graph) at day 5 and 8 pi. Naive Gfi1+/+ and Gfi1−/− P14 CD8 T cells were
also analyzed. (B) Dot plots are gated on P14 CD8 T cells and the percent IL-7Rαhi CD8 T
cells is indicated. (C, upper graph) The mean fluorescence intensity (MFI) of IL-7Rα
expression on the Gfi1+/+ (closed squares) and Gfi1−/− (open circles) populations of LCMV-
specific P14 CD8 T cells are shown. Data are mean ± SEM (n=8); *=p<0.05 (C, lower
graph) qRT-PCR analysis of IL-7Rα mRNA in Gfi1+/+ (filled squares) and Gfi1−/− (open
circles) effector P14 CD8 T cells purified by FACS. Each time point shows mean ± SEM (n=3);
**=p<0.01.
D–E. Gfi1−/− effector CD8 T cells exhibit decreased HDAC1 binding and increased
histone acetylation at the IL-7Rα promoter. Day 8 Gfi1+/+ or Gfi1−/− P14 effector CD8 T
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cells were purified using FACS and analyzed for HDAC1 binding (D) or acetylated H3K9
histones (E) or on the Il7ra promoter using chromatin immunoprecipitation followed by qRT-
PCR. The data in bar graphs were plotted as fold changes with respect to naïve Gfi1+/+ CD8
T cells set at 1 fold. Each time point shows mean ± SEM (n=3); *=p<0.05
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Figure 4. Gfi-1 is required for stable repression of IL-7Rα in effector CD8 T cells during infection
A. IL-7Rα repression following in vitro peptide stimulation is transient. Gfi1+/+ (upper
panel) and Gfi1−/− (lower panel) P14 CD8 T cells were stimulated with GP33–41 peptide for
12–48 hrs and IL-7Rα expression was measured on activated (CD69hi) CD8 T cells using flow
cytometry. Contour plots are gated on P14 CD8 T cells and the percent IL-7Rαhi cells is shown.
Data in plots are representative of 4 independent experiments.
B–C. Gfi1−/− effector CD8 T cells cannot maintain stable repression of IL-7Rα as infection
wanes. On day 5 pi, Gfi1+/+ (upper panels) or Gfi1−/− (lower panels) P14 CD8 T cells were
purified based on IL-7Rαlo staining by FACS and transferred separately into day 5 LCMV
infected recipients (left plots show sort purity). (B) Three days later (day 8 pi) donor P14 CD8
T cells in the spleen were analyzed for IL-7Rα expression by flow cytometry (right plots).
Contour plots are gated on P14 CD8 T cells and the percent of IL-7Rαhi cells is indicated.
(C) Line graph shows percent IL-7Rαhi Gfi1+/+ (filled squares) and Gfi1−/− (open circles) donor
effector P14 CD8 T cells in the blood each day post transfer. Data are mean ± SEM (n=4).
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Figure 5. Gfi-1 over expression represses Il7ra by inhibition of GABPα binding to il7rα promoter
A–B. Over expression of Gfi-1 represses IL-7Rα in effector CD8 T cells. Activated P14
CD8 T cells were transduced with RVs (marked by GFP+ expression) expressing Gfi-1 or
empty control vector and subsequently transferred into either LCMV infected mice (A) or naïve
mice (B). Seven days later GFP+ P14 CD8 T cells were analyzed for IL-7Rα expression using
flow cytometry. Contour plots are gated on donor P14 CD8 T cells and the percent IL-7Rαhi
effector CD8 T cells (either GFP+ or GFP−) are indicated. Note, specific reduction in the
frequency of IL-7Rαhi effector CD8 T cells in GFP+ P14 CD8 T cells transduced with Gfi-1
RV. The data are representative of 5 individual experiments.
C. Decreased promoter acetylation with Gfi-1 over expression. Day 8 P14 effector CD8 T
effector cells either transduced with Gfi-1 RV (GFP+) or not (GFP−) were purified using FACS
and analyzed for acetylated H3K9 histones using chromatin immunoprecipitation followed by
qRT-PCR. Effector CD8 T cell samples were compared to naive CD8 T cells set at 1 fold. The
data in bar graph show the mean ± SEM (n=3); *=p<0.05.
D–E. Gfi-1 inhibits GABPα binding on the Il7ra promoter in effector CD8 T cells. Day 8
Effector P14 CD8 T cells in which Gfi-1 was absent (D) or over expressed (E) were purified
using FACS and analyzed for GABPa binding on the Il7ra promoter using chromatin
immunoprecipitation followed by qRT-PCR. Effector CD8 T cell samples were compared to
naive CD8 T cells set at 1 fold. In (D), GABPa binding to the Il7ra promoter is compared
between Gfi1+/+ and Gfi1−/− effector P14 CD8 T cells, and in (E) effector P14 CD8 T cells
transduced with Gfi-1 RV (GFP+) or not (GFP−) are compared. The data in bar graph show
the mean ± SEM (n=3); *=p<0.05.
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